This week marks the beginning of the OnlyTheDifficult Worth Doing campaign to film Dr. Mackliff’s B.E.A.M treatment in Ecuador, the alternative treatment to antipsychotic drugs, that restores a life without symptoms of schizophrenia and several of his patients who have restored ‘lives worth living’. Please continue to follow the blog this week for exciting updates and photo shoots of friends and family wearing the onlythedifficult.org tee shirts.
Powerful antipsychotic medications are being used to treat children and teenagers with ADHD, aggression and behavior problems, a study finds, even though safer treatments are available and should be used first.
“There’s been concern that these medications have been overused, particularly in young children,” says Mark Olfson, a professor of psychiatry at Columbia University who led the study. It was published in JAMA Psychiatry. “Guidelines and clinical wisdom suggest that you really should be using a high degree of caution and only using them when other treatments have failed, as a last resort.”
Olfson and his colleagues looked at prescription data from about 60 percent of the retail pharmacies in the United States in 2006, 2008 and 2010. That included almost 852,000 children, teenagers and young adults. Teens were most likely to be prescribed antipsychotics, with 1.19 percent getting the drugs in 2010, compared to 0.11 percent in younger children. Boys were more likely to be given the medications.
Antipsychotic medications like clozapine and olanzapine are used to treat schizophrenia, bipolar disorder and some symptoms of autism. They have not been approved by the Food and Drug Administration to treat aggression and ADHD, but are prescribed off label to reduce disruptive behavior. (Mark Olfson, Marissa King, & Michael Schoenbaum, 2015). Antipsychotics are also prescribed to the elderly in nursing homes to subdue them in an inpatient setting.
New York Times article
The U.S. prescribes antipsychotics to children and adolescents at a rate six times greater than the U.K. which has socialized medicine and charges the same cost for any medicine. In June 2007, The New York Times reported that psychiatrists in Vermont and Minnesota topped the list of doctors receiving pharmaceutical company gifts and that this financial relationship corresponds to the “growing use of atypicals (new antipsychotics) in children.” From 2000 to 2005, drug maker payments to Minnesota psychiatrists rose more than six-fold to $1.6 million. During these same years, prescriptions of antipsychotics for children under the state’s insurance program rose more than nine-fold.